Executive DirectorAO, FAA, MBBS(HONS), MD, FRACP, FACP, FAHA, FAHMS, GAICD Professor Graham is the inaugural Executive Director of the Victor Chang Cardiac Research Institute, and a member of its Finance & Risk, Appeals, and Media and Communications Committees. He is the Des Renford Professor of Medicine, and Professor of Biotechnology and Biomolecular Science, University of New South Wales, and Professor (adjunct) of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio. Prof Graham is a Fellow of the Australian Academy of Science and the Australian Academy of Health & Medical Sciences, and foreign member, Royal Danish Academy of Sciences and Letters. He is a member of the American Association for Clinical Research, the American Society of Clinical Investigation and the American Heart Association, and a Life Member, Heart Foundation of Australia. Professor Graham is head of the Cardiac Receptor Biology Laboratory at the Victor Chang Cardiac Research Institute See the rest here: Fight Heart Disease - Victor Chang Cardiac Research Institute … Continue reading →

Sunday2:00 pm - 9:00 pm Arrival and Check-in Dinner Introductory Comments by GRC Site Staff / Welcome from the GRC Chair Discussion Leaders: Maria Kontaridis (Masonic Medical Research Laboratory / Beth Israel Deaconess Medical Center, USA) and William Pu (Harvard Medical School / Boston Children's Hospital, USA) Miguel Torres (Spanish National Cardiovascular Research Centre (CNIC), Spain) Discussion Chulan Kwon (Johns Hopkins University, USA) Discussion Jop van Berlo (University of Minnesota, USA) Discussion Nipavan Chiamvimonvat (University of California, Davis, USA) Discussion Breakfast Discussion Leaders: W. Jonathan Lederer (University of Maryland School of Medicine, USA) and Chris Glembotski (SDSU Heart Institute, USA) Jeffrey Saucerman (University of Virginia, USA) Discussion Walter Koch (Temple University, USA) Discussion Kimberly Dodge-Kafka (UConn Health, USA) Discussion Coffee Break Emilio Hirsch (University of Torino, Italy) Discussion Chris de Korte (Radboud University Medical Center Nijmegen, The Netherlands) Discussion Poster Previews Lunch Free Time Organizers: Lucie Carrier (University Medical Center Hamburg-Eppendorf, Germany) and Maria Kontaridis (Masonic Medical Research Laboratory / Beth Israel Deaconess Medical Center, USA) Poster Session Dinner Discussion Leaders: Federica Accornero (Ohio State University, USA) and Stefan Engelhardt (Technische Universitt Mnchen, Germany) Susmita Sahoo (Icahn School of Medicine at Mount Sinai, USA) Discussion Saptarsi Haldar (Gladstone Institutes / … Continue reading →

Our understanding of the mechanisms controlling tissue repair and organ regeneration following injury has increased greatly over the past decade. Nevertheless, there has been little progress translating basic science discoveries into clinical practice. As our understanding of the unique roles of fibroblasts, macrophages, and stem and tissue progenitor cell populations are rapidly being elucidated, we expect new modalities to regulate tissue repair, regeneration, and fibrosis will soon be evaluated in clinical trials. Recent advances include differentiation of pluripotent stem cells (embryonic and induced) into hepatic, intestinal, cardiac, and pancreatic cells that may be used to replace defective cells and mend injured tissues. We also have an emerging understanding of the role of the immune system and how persistent recruitment and activation of specific cell types can promote chronic wounds, guide organ regeneration, or contribute to the development of pathological fibrosis. The goal of this meeting is to bring together academic researchers, clinicians, and members of the pharmaceutical industry to discuss the most recent advances in the fields of tissue repair, organ regeneration and fibrosis and to identify key roadblocks that are slowing progress in each of these important areas. By bringing together a diverse group of researchers interested in all … Continue reading →